New St. John's Wort Study Forming

by Diane Lofshult on Jun 01, 2003

The National Institutes of Health (NIH) is launching a new study to assess the effectiveness and safety of St. John’s Wort for the treatment of minor depression. The 4-year study will take place at three sites—in Boston, Los Angeles and Pittsburgh. Enrollment is expected to be around 300 participants, all suffering from minor depression.

Study participants will be randomly given St. John’s Wort, the drug citalopram (Celexa) or a placebo and will then be assessed for changes in symptoms, functioning and quality of life. The study is open to both genders. Subjects must be between 18 and 85 years old and have had symptoms of minor depression for at least 6 months, among other criteria. For more information on this upcoming study, contact

IDEA Health Fitness Source, Volume 2004, Issue 6

Find the Perfect Job

More jobs, more applicants and more visits than any other fitness industry job board.

© 2003 by IDEA Health & Fitness Inc. All rights reserved. Reproduction without permission is strictly prohibited.

About the Author

Diane Lofshult

Diane Lofshult IDEA Author/Presenter

Diane Lofshult is an award-winning freelance author who specializes in nutrition and weight management topics. She is the founder of In Other Words, an editorial consulting firm based in Solana Beach, California. Reach her at